Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,930 | 523 | 99.2% |
| Education | $64.43 | 8 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,292 | 76 | $0 (2024) |
| Lilly USA, LLC | $1,119 | 83 | $0 (2024) |
| Novo Nordisk Inc | $720.06 | 51 | $0 (2024) |
| PFIZER INC. | $620.75 | 37 | $0 (2024) |
| Amgen Inc. | $551.32 | 37 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $465.71 | 33 | $0 (2024) |
| ABBVIE INC. | $347.61 | 18 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $329.72 | 23 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $300.43 | 20 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $270.79 | 18 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $962.45 | 53 | Lilly USA, LLC ($198.96) |
| 2023 | $676.09 | 40 | AbbVie Inc. ($190.51) |
| 2022 | $340.24 | 22 | Lilly USA, LLC ($40.00) |
| 2021 | $1,356 | 89 | Lilly USA, LLC ($212.31) |
| 2020 | $1,031 | 63 | Lilly USA, LLC ($152.58) |
| 2019 | $1,355 | 92 | AstraZeneca Pharmaceuticals LP ($250.20) |
| 2018 | $1,214 | 88 | AstraZeneca Pharmaceuticals LP ($270.09) |
| 2017 | $1,058 | 84 | AstraZeneca Pharmaceuticals LP ($206.04) |
All Payment Transactions
531 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: Diabetes | ||||||
| 12/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Cardio-renal | ||||||
| 11/25/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.70 | General |
| 11/20/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/18/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/14/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Diabetes Care | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $20.89 | General |
| 11/01/2024 | Philips North America LLC | (CK7) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $21.55 | General |
| Category: Medical Device | ||||||
| 10/30/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Diabetes | ||||||
| 10/26/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: PAIN | ||||||
| 10/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: PSYCHIATRY | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $21.74 | General |
| 09/25/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Diabetes | ||||||
| 09/16/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: Diabetes Care | ||||||
| 09/11/2024 | Philips North America LLC | (CK7) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: Medical Device | ||||||
| 09/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Diabetes | ||||||
| 08/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Diabetes | ||||||
| 08/08/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 486 | 1,016 | $137,957 | $55,923 |
| 2022 | 8 | 299 | 501 | $71,765 | $25,911 |
| 2021 | 15 | 610 | 1,487 | $202,103 | $80,008 |
| 2020 | 15 | 692 | 2,028 | $262,742 | $106,015 |
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 89 | 339 | $82,637 | $27,830 | 33.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 41 | 62 | $16,550 | $7,635 | 46.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 47 | 47 | $7,560 | $5,635 | 74.5% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 15 | 67 | $6,700 | $4,490 | 67.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 36 | 53 | $7,460 | $2,872 | 38.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 84 | 230 | $3,465 | $1,932 | 55.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $3,530 | $1,582 | 44.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 33 | 33 | $1,320 | $942.81 | 71.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 15 | 23 | $1,675 | $790.47 | 47.2% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 34 | 34 | $1,700 | $722.70 | 42.5% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 12 | 14 | $1,050 | $703.92 | 67.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 32 | $1,600 | $323.63 | 20.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 11 | 11 | $480.00 | $187.00 | 39.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 29 | 44 | $1,320 | $150.04 | 11.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 13 | 13 | $910.00 | $126.60 | 13.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 89 | 197 | $49,020 | $14,928 | 30.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 40 | 40 | $7,110 | $4,900 | 68.9% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 30 | 64 | $6,400 | $3,275 | 51.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 36 | $5,400 | $1,553 | 28.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 17 | 18 | $730.00 | $493.40 | 67.6% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 17 | 18 | $900.00 | $379.06 | 42.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 65 | 113 | $1,755 | $330.27 | 18.8% |
| 81002 | Urinalysis, manual test | Office | 2022 | 12 | 15 | $450.00 | $51.64 | 11.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 126 | 471 | $121,175 | $42,055 | 34.7% |
| 99487 | Complex chronic care management services, first 60 minutes clinical staff time per calendar month | Office | 2021 | 62 | 343 | $34,300 | $19,741 | 57.6% |
About Dr. Vikrant Salaria, M.D
Dr. Vikrant Salaria, M.D is a Internal Medicine healthcare provider based in Council Bluffs, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1043211493.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vikrant Salaria, M.D has received a total of $7,994 in payments from pharmaceutical and medical device companies, with $962.45 received in 2024. These payments were reported across 531 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($7,930).
As a Medicare-enrolled provider, Salaria has provided services to 2,087 Medicare beneficiaries, totaling 5,032 services with total Medicare billing of $267,857. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Council Bluffs, IA
- Active Since 08/09/2005
- Last Updated 03/05/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1043211493
Products in Payments
- FARXIGA (Drug) $688.62
- TRULICITY (Drug) $456.51
- ELIQUIS (Drug) $388.58
- Ozempic (Drug) $337.99
- ENTRESTO (Drug) $300.43
- XARELTO (Drug) $280.60
- SYMBICORT (Drug) $259.01
- JANUVIA (Drug) $253.96
- CHANTIX (Drug) $245.10
- QULIPTA (Drug) $229.53
- MOUNJARO (Drug) $212.29
- UBRELVY (Drug) $204.39
- Trintellix (Drug) $201.31
- Aimovig (Biological) $193.99
- Tresiba (Drug) $193.06
- INVOKANA (Drug) $179.09
- Otezla (Drug) $176.86
- TRINTELLIX (Drug) $164.79
- EMGALITY (Drug) $159.54
- JARDIANCE (Drug) $136.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Council Bluffs
Alan Kricsfeld, Md, MD
Internal Medicine — Payments: $68,678
Diana Rabadi-Marar, M.d, M.D
Internal Medicine — Payments: $37,016
Matthew Fryzek, M.d, M.D
Internal Medicine — Payments: $35,526
Isam Marar, M.d, M.D
Internal Medicine — Payments: $30,637
Jeremy Pepin, M.d, M.D
Internal Medicine — Payments: $20,958
Barry Kricsfeld, Md Facp, MD FACP
Internal Medicine — Payments: $19,128